VACCITECH

Summary

Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 121 M

Avg. Deal Size£ 121 M

Market Context

Senior Management

Bill Enright
CEO